Gene · 3832
Papers3,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation. | Transl Cancer Res | 2022 | 36093542 | PubTator, text mining | PubMed |
| KIF11 Mutation with Congenital Microcephaly and Chorioretinal Lacunae. | Ophthalmol Retina | 2022 | 36084995 | PubTator, text mining | PubMed |
| Discovery of Quinacrine as a Potent Topo II and Hsp90 Dual-Target Inhibitor, Repurposing for Cancer Therapy. | Molecules | 2022 | 36080326 | PubTator, text mining | PubMed |
| Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG). | Cancers (Basel) | 2022 | 36077742 | PubTator, text mining | PubMed |
| Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at 16q11.2 and MAPT H1 loci. | Brain | 2022 | 36074904 | PubTator, text mining | PubMed |
| Predicting AURKA as a novel therapeutic target for NPC: A comprehensive analysis based on bioinformatics and validation. | Front Genet | 2022 | 36072667 | PubTator, text mining | PubMed |
| Aberrant mitochondrial homeostasis at the crossroad of musculoskeletal ageing and non-small cell lung cancer. | PLoS One | 2022 | 36067173 | PubTator, text mining | PubMed |
| Effective Protein-Ligand Docking Strategy via Fragment Reuse and a Proof-of-Concept Implementation. | ACS Omega | 2022 | 36061673 | PubTator, text mining | PubMed |
| KIFC1: A Reliable Prognostic Biomarker in Rb-positive Triple-negative Breast Cancer Patients Treated With Doxorubicin in Combination With Abemaciclib. | Cancer Diagn Progn | 2022 | 36060015 | PubTator, text mining | PubMed |
| Using a comprehensive approach to investigate the interaction between Kinesin-5/Eg5 and the microtubule. | Comput Struct Biotechnol J | 2022 | 36051882 | PubTator, text mining | PubMed |
| Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics. | Comput Biol Med | 2022 | 36049413 | PubTator, text mining | PubMed |
| Vanguard is a Glucose Deprivation-Responsive Long Non-Coding RNA Essential for Chromatin Remodeling-Reliant DNA Repair. | Adv Sci (Weinh) | 2022 | 36047643 | PubTator, text mining | PubMed |
| CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | Oncogene | 2022 | 36042349 | PubTator, text mining | PubMed |
| Protein arginine methyltransferase 5 is essential for oncogene product EWSR1-ATF1-mediated gene transcription in clear cell sarcoma. | J Biol Chem | 2022 | 36041632 | PubTator, text mining | PubMed |
| Compendium of proteins containing segments that exhibit zero-tolerance to amino acid variation in humans. | Protein Sci | 2022 | 36040257 | PubTator, text mining | PubMed |
| Cancer cell histone density links global histone acetylation, mitochondrial proteome and histone acetylase inhibitor sensitivity. | Commun Biol | 2022 | 36030322 | PubTator, text mining | PubMed |
| KIF11 Is a Promising Therapeutic Target for Thyroid Cancer Treatment. | Comput Math Methods Med | 2022 | 36017147 | PubTator, text mining | PubMed |
| Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing. | Vaccines (Basel) | 2022 | 36016137 | PubTator, text mining | PubMed |
| Multicomponent Reactions for the Synthesis of Active Pharmaceutical Ingredients. | Pharmaceuticals (Basel) | 2022 | 36015157 | PubTator, text mining | PubMed |
| Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions. | Pharmaceuticals (Basel) | 2022 | 36015096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3832/papers?page=37